BioCryst, Idera merging

BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) said Jan. 22 it will merge with Idera Pharmaceuticals Inc. (NASDAQ:IDRA) to form a company focused on rare diseases. The combined company will be renamed when the merger closes, which is

Read the full 358 word article

User Sign In